C World Wide Group Holding A Collegium Pharmaceutical, Inc Transaction History

C World Wide Group Holding A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$10.62 - $16.59 $2.51 Million - $3.92 Million	-236,021 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$14.78 - $19.68 $1.24 Million - $1.65 Million	-83,729 Reduced 26.19%	236,021 $4.05 Million
Q3 2018 Nov 05, 2018	BUY	$14.16 - $24.3 $2.43 Million - $4.17 Million	171,506 Added 115.69%	319,750 $4.71 Million
Q2 2018 Aug 03, 2018	BUY	$21.79 - $28.29 $3.23 Million - $4.19 Million	148,244 New	148,244 $3.54 Million

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.